Cher L - Search Results

1

Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patients.

Arulananda S, Lynam J, Sem Liew M, Wada M, Cher L, Gan HK. Arulananda S, et al. Among authors: cher l. Intern Med J. 2018 Oct;48(10):1206-1214. doi: 10.1111/imj.14000. Intern Med J. 2018. PMID: 29923272

2

An Australian experience with temozolomide for the treatment of recurrent high grade gliomas.

Harris MT, Rosenthal MA, Ashley DL, Cher L. Harris MT, et al. Among authors: cher l. J Clin Neurosci. 2001 Jul;8(4):325-7. doi: 10.1054/jocn.2000.0809. J Clin Neurosci. 2001. PMID: 11437571

3

Temozolomide-induced flare in high-grade gliomas: a new clinical entity.

Rosenthal MA, Ashley DL, Cher L. Rosenthal MA, et al. Among authors: cher l. Intern Med J. 2002 Jul;32(7):346-8. doi: 10.1046/j.1445-5994.2002.00242.x. Intern Med J. 2002. PMID: 12088355

4

Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme.

Chua SL, Rosenthal MA, Wong SS, Ashley DM, Woods AM, Dowling A, Cher LM. Chua SL, et al. Among authors: cher lm. Neuro Oncol. 2004 Jan;6(1):38-43. doi: 10.1215/S1152851703000188. Neuro Oncol. 2004. PMID: 14769139 Free PMC article. Clinical Trial.

5

BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide.

Rosenthal MA, Ashley DL, Cher L. Rosenthal MA, et al. Among authors: cher l. J Clin Neurosci. 2004 May;11(4):374-5. doi: 10.1016/j.jocn.2003.01.002. J Clin Neurosci. 2004. PMID: 15080950 Clinical Trial.

6

Phase II study of two-weekly temozolomide in patients with high-grade gliomas.

Wong S, Rosenthal MA, Dowling A, Jennens R, Woods AM, Ashley D, Cher L. Wong S, et al. Among authors: cher l. J Clin Neurosci. 2006 Jan;13(1):18-22. doi: 10.1016/j.jocn.2004.10.018. Epub 2005 Dec 13. J Clin Neurosci. 2006. PMID: 16356721 Clinical Trial.

7

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab.

Gan HK, Azad A, Cher L, Mitchell PL. Gan HK, et al. Among authors: cher l. Neuro Oncol. 2010 Feb;12(2):212-5. doi: 10.1093/neuonc/nop021. Epub 2009 Dec 24. Neuro Oncol. 2010. PMID: 20150388 Free PMC article.

8

A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors.

Gan HK, Rosenthal MA, Dowling A, Kalnins R, Algar E, Wong N, Benson A, Woods AM, Cher L. Gan HK, et al. Among authors: cher l. Neuro Oncol. 2010 May;12(5):500-7. doi: 10.1093/neuonc/nop065. Epub 2010 Feb 8. Neuro Oncol. 2010. PMID: 20406900 Free PMC article. Clinical Trial.

9

Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy.

Ananda S, Nowak AK, Cher L, Dowling A, Brown C, Simes J, Rosenthal MA; Cooperative Trials Group for Neuro-Oncology (COGNO). Ananda S, et al. Among authors: cher l. J Clin Neurosci. 2011 Nov;18(11):1444-8. doi: 10.1016/j.jocn.2011.02.026. Epub 2011 Aug 2. J Clin Neurosci. 2011. PMID: 21813279 Clinical Trial.

10

A single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide.

Wong SF, Gan HK, Cher L. Wong SF, et al. Among authors: cher l. J Clin Neurosci. 2012 Nov;19(11):1501-5. doi: 10.1016/j.jocn.2012.04.001. Epub 2012 Sep 17. J Clin Neurosci. 2012. PMID: 22995759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters